James Coward v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2020)
Case summary [AI summaries can sometimes make mistakes]
James Coward filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered Guillain-Barre syndrome (GBS) as a result of influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccines administered on October 3, 2017. The respondent conceded that Mr.
Coward is entitled to compensation, as his condition satisfied the criteria set forth in the Vaccine Injury Table and its Qualifications and Aids to Interpretation. Consequently, a ruling on entitlement was issued on September 15, 2020, finding him eligible for an award.
Subsequently, on December 18, 2020, the respondent filed a proffer proposing a total award of $139,665.54, which included $135,000.00 for pain and suffering and $4,665.54 for past unreimbursed expenses. Mr.
Coward agreed with this proposed award. The Chief Special Master issued a decision on December 21, 2020, awarding Mr.
Coward the stipulated lump sum of $139,665.54, compensating him for all damages available under the Vaccine Act.